Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001104659-20-080550

Options or other derivatives

  • Director acquired 18,760 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Quart Barry D Director 2020-06-30 Grant or award · Share Option +18,760 18,760 D
Loading xslF345X03/a4.xml…